ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma

ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma

Detalles Bibliográficos
Main Authors: Carvalho, D, Taylor, KR, Olaciregui, NG, Molinari, V, Clarke, M, Mackay, A, Ruddle, R, Henley, A, Valenti, M, Hayes, A, Brandon, ADH, Eccles, SA, Raynaud, F, Boudhar, A, Monje, M, Popov, S, Moore, AS, Mora, J, Cruz, O, Vinci, M, Brennan, PE, Bullock, AN, Carcaboso, AM, Jones, C
Formato: Journal article
Idioma:English
Publicado: Nature Research 2019

Títulos similares

Títulos similares